Dr
Rob
Walton

Senior Patent Attorney

Birmingham Office

Engineering

Telephone. +44(0) 121 265 7930
Email. [email protected]

Experience

Robert advises in the physics, engineering and electronics fields, with specialisms in the fields of medical devices, non-conventional manufacturing, MEMs, micropower generation and rapid prototyping. Prior to joining the intellectual property profession he completed a Mechanical Engineering MEng degree and a PhD in nuclear batteries at the University of Birmingham.

Robert works with a broad range of clients including multi-national corporations, universities, SMEs and lone inventors. His practice includes patent drafting and prosecution, due diligence, freedom to operate opinions and oppositions and appeals work before the EPO. In recent years the majority of his time has been spent working on oppositions and appeals before the EPO.

Robert graduated from the University of Birmingham in 2010 with a First Class MEng degree in Mechanical Engineering. He then successfully researched a PhD in Nuclear Batteries at the same university. Robert's PhD research involved elements of electronics, optics and physics and entailed designing, manufacturing, testing and modelling nuclear batteries. His undergraduate and postgraduate studies have provided him with a broad understanding of mechanics as well as specialised knowledge of topics including MEMs, rapid prototyping and micro-power generation.

Robert joined the intellectual property profession, in HGF’s Birmingham office, in July 2014 as a trainee patent attorney and qualified as a UK and European patent attorney in 2018. In his spare time Robert enjoys playing squash and travelling.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MENG

1st Class in Mechanical Engineering at the University of Birmingham

PHD

in Nuclear Batteries at the University of Birmingham

Publications

G01/18: An appeal is deemed ‘not filed’ if the appeal fee is paid late and/or the notice of appeal is filed late

View publication online

G01/18: An appeal is deemed ‘not filed’ if the appeal fee is paid late and/or the notice of appeal is filed late

View publication online

Conferences: 2020

October 21st 2020

Opposition Matters - EPO

Attended

Related News

From Theoretical Proposals to Commercial Reality: The Rise of Innovation and Patent Filings in Quantum Computing

The possibility of quantum computing was first seriously proposed in the early 1980s and is widely regarded as having enormous potential to deliver a step change in the complexity of …

Read article
Event - 3rd February 2023

The European Patent Office are running an inspiring collaborative art competition for children

To celebrate the 50th anniversary of the signing of the European Patent Convention, The European Patent Office (EPO) is running a collaborative art competition for primary schools on the topic …

Event details
Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.